Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | BRAF |
Variant | G596V |
Impact List | missense |
Protein Effect | loss of function - predicted |
Gene Variant Descriptions | BRAF G596V lies within the protein kinase domain of the Braf protein (UniProt.org). G596V results in activation of Erk in zebrafish models (PMID: 19376813), but impaired Braf kinase activity and does not activate downstream Mek and Erk in cell culture (PMID: 16439621), and is therefore predicted to lead to a loss of Braf protein function. |
Associated Drug Resistance | |
Category Variants Paths |
BRAF mutant BRAF G596X BRAF G596V BRAF mutant BRAF inact mut BRAF G596V |
Transcript | NM_004333.6 |
gDNA | chr7:g.140753348C>A |
cDNA | c.1787G>T |
Protein | p.G596V |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001378468.1 | chr7:g.140753348C>A | c.1787G>T | p.G596V | RefSeq | GRCh38/hg38 |
NM_004333.5 | chr7:g.140753348C>A | c.1787G>T | p.G596V | RefSeq | GRCh38/hg38 |
NM_004333.6 | chr7:g.140753348C>A | c.1787G>T | p.G596V | RefSeq | GRCh38/hg38 |
NM_001354609.1 | chr7:g.140753348C>A | c.1787G>T | p.G596V | RefSeq | GRCh38/hg38 |
NM_004333 | chr7:g.140753348C>A | c.1787G>T | p.G596V | RefSeq | GRCh38/hg38 |
NM_001378467.1 | chr7:g.140753357C>A | c.1787G>T | p.G596V | RefSeq | GRCh38/hg38 |
XM_005250045 | chr7:g.140753348C>A | c.1787G>T | p.G596V | RefSeq | GRCh38/hg38 |
NM_001378474.1 | chr7:g.140753348C>A | c.1787G>T | p.G596V | RefSeq | GRCh38/hg38 |
NM_001354609.2 | chr7:g.140753348C>A | c.1787G>T | p.G596V | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
BRAF G596V | lung non-small cell carcinoma | predicted - sensitive | Vemurafenib | Case Reports/Case Series | Actionable | In a clinical case study, a non-small cell lung cancer patient harboring BRAF G596V demonstrated a partial response following treatment with Zelboraf (vemurafenib) (PMID: 26200454). | 26200454 |